Silence Therapeutics (SLN) Free Cash Flow (2020 - 2025)
Historic Free Cash Flow for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to -$10.9 million.
- Silence Therapeutics' Free Cash Flow rose 5720.18% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.6 million, marking a year-over-year decrease of 1413.7%. This contributed to the annual value of -$67.9 million for FY2024, which is 1986.97% down from last year.
- Latest data reveals that Silence Therapeutics reported Free Cash Flow of -$10.9 million as of Q3 2025, which was up 5720.18% from -$21.8 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Free Cash Flow ranged from a high of $37.0 million in Q2 2021 and a low of -$27.5 million during Q4 2024
- In the last 5 years, Silence Therapeutics' Free Cash Flow had a median value of -$11.0 million in 2022 and averaged -$11.5 million.
- As far as peak fluctuations go, Silence Therapeutics' Free Cash Flow plummeted by 2144647.82% in 2021, and later skyrocketed by 6753.95% in 2024.
- Over the past 5 years, Silence Therapeutics' Free Cash Flow (Quarter) stood at -$5.8 million in 2021, then tumbled by 176.92% to -$16.1 million in 2022, then crashed by 40.46% to -$22.5 million in 2023, then dropped by 22.16% to -$27.5 million in 2024, then soared by 60.41% to -$10.9 million in 2025.
- Its last three reported values are -$10.9 million in Q3 2025, -$21.8 million for Q2 2025, and -$12.3 million during Q1 2025.